{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:21:13Z","timestamp":1773339673345,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24283"],"award-info":[{"award-number":["23K24283"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K18827"],"award-info":[{"award-number":["24K18827"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.adro.2025.101916","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:26:56Z","timestamp":1760002016000},"page":"101916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computed Tomography-Based Radiomics Prediction of Biochemical Failure and Distant Metastasis in Patients With High- and Very High-Risk Localized Prostate Cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"Takanori","family":"Adachi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rihito","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hirashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-2097","authenticated-orcid":false,"given":"Mitsuhiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2025.101916_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2025.101916_bib0002","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.25467","article-title":"Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer","volume":"117","author":"Alicikus","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2025.101916_bib0003","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/iju.14011","article-title":"Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions","volume":"26","author":"Hatano","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.adro.2025.101916_bib0004","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41391-023-00712-z","article-title":"Biochemical recurrence in patients with prostate cancer after primary definitive therapy: Treatment based on risk stratification","volume":"27","author":"Shore","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.adro.2025.101916_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","article-title":"Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer","volume":"70","author":"Kuban","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101916_bib0006","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.eururo.2022.07.011","article-title":"Local failure events in prostate cancer treated with radiotherapy: A pooled analysis of 18 randomized trials from the meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (Leviathan)","volume":"82","author":"Ma","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2025.101916_bib0007","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 1; 2024. Accessed February 27, 2024. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1459"},{"key":"10.1016\/j.adro.2025.101916_bib0008","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1200\/JCO.2000.18.19.3352","article-title":"Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer","volume":"18","author":"Kattan","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0009","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.urology.2007.03.060","article-title":"Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer","volume":"70","author":"Zelefsky","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.adro.2025.101916_bib0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.prro.2013.05.008","article-title":"Combining prostate-specific antigen nadir and time to nadir allows for early identification of patients at highest risk for development of metastasis and death following salvage radiation therapy","volume":"4","author":"Jackson","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0011","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210539","article-title":"Overview of radiomics in prostate imaging and future directions","volume":"95","author":"Cho","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2025.101916_bib0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fonc.2020.00731","article-title":"Radiomics of multiparametric MRI to predict biochemical recurrence of localized prostate cancer after radiation therapy","volume":"10","author":"Zhong","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phro.2018.06.005","article-title":"Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features","volume":"7","author":"Dinis Fernandes","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0014","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jmri.26178","article-title":"Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings","volume":"48","author":"Shiradkar","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmri.25335","article-title":"Haralick textural features on T2-weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer","volume":"45","author":"Gnep","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103163","article-title":"A novel imaging-based nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI","volume":"63","author":"Li","year":"2021","journal-title":"EBiomedicine"},{"key":"10.1016\/j.adro.2025.101916_bib0017","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/cancers12040814","article-title":"External validation of an MRI-derived radiomics model to predict biochemical recurrence after surgery for high-risk prostate cancer","volume":"12","author":"Bourbonne","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2025.101916_bib0018","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3389\/fonc.2019.00807","article-title":"MRI-derived radiomics to guide post-operative management for high-risk prostate cancer","volume":"9","author":"Bourbonne","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0019","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1007\/s00330-023-09642-9","article-title":"Role of radiomic analysis of [18F] fluoromethylcholine PET\/CT in predicting biochemical recurrence in a dataset of intermediate and high risk prostate cancer patients at initial staging","volume":"33","author":"Marturano","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.adro.2025.101916_bib0020","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00259-020-05140-y","article-title":"Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68ga]Ga-PSMA-11 PET\/MRI","volume":"48","author":"Papp","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0021","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijrobp.2021.07.1714","article-title":"Dose-based radiomic analysis (dosiomics) for intensity modulated radiation therapy in patients with prostate cancer: Correlation between planned dose distribution and biochemical failure","volume":"112","author":"Murakami","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101916_bib0022","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00066-020-01677-x","article-title":"Cone-beam computed tomography-based radiomics in prostate cancer: A mono-institutional study","volume":"196","author":"Bosetti","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.adro.2025.101916_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mri.2023.12.009","article-title":"A machine learning radiomics model based on bpMRI to predict bone metastasis in newly diagnosed prostate cancer patients","volume":"107","author":"Xinyang","year":"2024","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109020","article-title":"A radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients","volume":"128","author":"Zhang","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.adro.2025.101916_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103395","article-title":"Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer","volume":"68","author":"Hou","year":"2021","journal-title":"EBiomedicine"},{"key":"10.1016\/j.adro.2025.101916_bib0026","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00432-023-05574-5","article-title":"Deep learning algorithm-based multimodal MRI radiomics and pathomics data improve prediction of bone metastases in primary prostate cancer","volume":"150","author":"Zhang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0027","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mri.2019.03.007","article-title":"MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer","volume":"60","author":"Wang","year":"2019","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0028","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1007\/s00259-020-04864-1","article-title":"A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients","volume":"47","author":"Peeken","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0029","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.adro.2025.101916_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10147-011-0324-1","article-title":"Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol","volume":"17","author":"Norihisa","year":"2012","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.adro.2025.101916_bib0031","doi-asserted-by":"crossref","first-page":"131.e9","DOI":"10.1016\/j.urolonc.2020.09.026","article-title":"Increased risk of disease progression in younger men: Analysis of factors predicting biochemical failure and castration-resistant prostate cancer after high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer","volume":"39","author":"Aizawa","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0032","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s10147-019-01478-y","article-title":"Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation","volume":"24","author":"Aizawa","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0033","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/iju.15535","article-title":"Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review","volume":"31","author":"Aizawa","year":"2024","journal-title":"Int J Urol"},{"issue":"8","key":"10.1016\/j.adro.2025.101916_bib0034","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.21873\/anticanres.16538","article-title":"Impact of Long-term Adjuvant Hormonal Therapy in High-dose IMRT for Unfavorable Locally Advanced Prostate Cancer","volume":"43","author":"Ogata","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2025.101916_bib0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2025.101916_bib0036","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D Slicer as an image computing platform for the Quantitative Imaging Network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.adro.2025.101916_bib0037","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.adro.2025.101916_bib0038","first-page":"287","article-title":"IBSI: An international community radiomics standardization initiative","volume":"59","author":"Hatt","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2025.101916_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13869","article-title":"Feature selection methods and predictive models in CT lung cancer radiomics","volume":"24","author":"Ge","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.adro.2025.101916_bib0040","first-page":"519","article-title":"Variable importance in binary regression trees and forests","volume":"1","author":"Ishwaran","year":"2007","journal-title":"Electr J Stat"},{"key":"10.1016\/j.adro.2025.101916_bib0041","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00330-021-08150-y","article-title":"Vertebral MRI-based radiomics model to differentiate multiple myeloma from metastases: influence of features number on logistic regression model performance","volume":"32","author":"Liu","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.adro.2025.101916_bib0042","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.adro.2025.101916_bib0043","series-title":"R: A language and environment for statistical computing","year":"2018"},{"key":"10.1016\/j.adro.2025.101916_bib0044","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.22755","article-title":"Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy","volume":"110","author":"Morgan","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2025.101916_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13904","article-title":"Stability of dosiomic features against variations in dose calculation: An analysis based on a dataset of prostate external beam radiotherapy patients","volume":"24","author":"Sun","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.adro.2025.101916_bib0046","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejmp.2021.09.010","article-title":"On dose cube pixel spacing pre-processing for features extraction stability in dosiomic studies","volume":"90","author":"Placidi","year":"2021","journal-title":"Phys Med"},{"key":"10.1016\/j.adro.2025.101916_bib0047","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1002\/mp.16376","article-title":"Identification of reproducible radiomic features from on-board volumetric images: A multi-institutional phantom study","volume":"50","author":"Adachi","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2025.101916_bib0048","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/s41598-018-20713-6","article-title":"Effect of tube current on computed tomography radiomic features","volume":"8","author":"Mackin","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2025.101916_bib0049","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s10278-024-01013-0","article-title":"A novel data augmentation method for radiomics analysis using image perturbations","volume":"37","author":"Lo Iacono","year":"2024","journal-title":"J Imaging Inform Med"},{"key":"10.1016\/j.adro.2025.101916_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14475","article-title":"Prospective external validation of radiomics-based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non-small-cell lung cancer: A multi-institutional analysis","volume":"25","author":"Adachi","year":"2024","journal-title":"J Appl Clin Med Phys"},{"issue":"10","key":"10.1016\/j.adro.2025.101916_bib0051","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/iju.15535","article-title":"Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review","volume":"31","author":"Aizawa","year":"2024","journal-title":"Int J Urol"},{"key":"10.1016\/j.adro.2025.101916_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11604-024-01646-9","article-title":"PSMA PET\/CT imaging and its application to prostate cancer treatment","volume":"43","author":"Otani","year":"2025","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.adro.2025.101916_bib0053","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/jjco\/hyac035","article-title":"Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer","volume":"52","author":"Terada","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.adro.2025.101916_bib0054","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.21873\/anticanres.17623","article-title":"Clinical Outcomes of Metastasis-directed Therapy for Oligo-metastatic Prostate Cancer Diagnosed Using PSMA-PET\/CT or Whole-body MRI","volume":"45","author":"Aizawa","year":"2025","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2025.101916_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40644-019-0239-z","article-title":"Clinical impact of variability on CT radiomics and suggestions for suitable feature selection: a focus on lung cancer","volume":"19","author":"Lee","year":"2019","journal-title":"Cancer Imaging"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425002039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109425002039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:26:14Z","timestamp":1773303974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109425002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2452109425002039"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2025.101916","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computed Tomography-Based Radiomics Prediction of Biochemical Failure and Distant Metastasis in Patients With High- and Very High-Risk Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2025.101916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101916"}}